Live Quote · NASDAQZYMEHealthcare· Biotechnology

Zymeworks Inc.

$26.14▼ 2.68%($-0.72)
MKT CAP $1.82BNEXT EARNINGS Mar 1, 2027
50%
Bullish
TickerSpark Score
73/100
▌ Solid
40
Valuation
85
Profitability
100
Growth
80
Health
60
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ZYME research report →

Analyst Price Target
$42.71+63.4% vs. today

Range $32 – $55

Analyst RatingBuy
21 Buy2 Hold0 Sell

Price Chart

+9.74% · this period
$31.46$26.63$21.81Nov 20May 26Nov 20
52-Week Range44% of range
Low
$21.52
Current
$26.14
High
$31.97